The realm of cardiac electrophysiology has long relied on the patch-clamp technique as an unrivaled method for probing the electrical and biophysical characteristics of excitable cells. Its precision in measuring ion channel currents at the single-cell level has provided invaluable insights into cardiac function and pathology. Despite its critical role, traditional patch-clamp methods remain hindered by inherent limitations: the labor-intensive, slow procedures restrict throughput, as each cell must be carefully interrogated one-by-one. This bottleneck has posed a significant challenge in fields like cardiac drug development and personalized medicine, especially when dealing with human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), which have emerged as promising models to study cardiac physiology and disease.
Addressing this critical gap, a team of researchers spearheaded by Seibertz and colleagues has introduced a groundbreaking protocol that revolutionizes the throughput of ion channel current measurement in hiPSC-CMs. Central to their approach is the use of advanced planar patch-clamp robotics, a technology that amalgamates automation with precision to handle multiple cells simultaneously. Their method harnesses the robust mechanics of planar patch-clamp technology, departing from traditional glass pipette-based techniques, facilitating parallel recordings that dramatically accelerate data acquisition without compromising data fidelity.
One of the remarkable aspects of this protocol lies not only in its high-throughput capability but also in its modular design. The researchers have meticulously optimized patch-clamp protocols tailored to the specific electrophysiological characterization of key cardiac ion channels, namely K_ir2.1, Na_V1.5, Ca_V1.2, K_v11.1, and K_ir3.1/3.4. These channels are fundamental players in dictating cardiac rhythm and contractile function. By capturing the simultaneous activity of these channels, their system offers an enhanced functional perspective on the cardiac action potentials and arrhythmogenic potentials of hiPSC-CMs, a crucial step for deciphering cardiac pathophysiology.
The application of this automated patch-clamp system transcends merely technical convenience; it fundamentally transforms the experimental workflow. Conventionally, patch-clamping required electrophysiological expertise and meticulous manual execution, limiting experiments to small sample sizes and extensive time frames. The optimized robot-enabled approach allows sequential application of different patch protocols on the same cell, leveraging liquid handling automation. This innovative feature substantially increases experimental data density and experimental throughput by operating continuously in the whole-cell configuration.
The protocol also outlines streamlined procedures for cell collection, preparation, and handling, which are pivotal for ensuring high-quality electrophysiological recordings. hiPSC-CMs, derived from human pluripotent stem cells through directed differentiation, demand careful handling to preserve their electrophysiological phenotype. Ensuring cell viability and proper membrane integrity during preparation is vital for successful patch-clamp recordings, especially when multiplexing assays on multiple ion channels consecutively.
Importantly, the researchers highlight that despite the sophistication of their system, this approach is accessible to non-electrophysiologists with fundamental experience in cell culture and basic handling techniques. This democratization of high-throughput electrophysiological measurement opens research possibilities not only for specialized cardiac electrophysiology labs but also for pharmacology, toxicology, and translational medicine sectors keen on cardiac safety screening and drug discovery.
The implications of this high-throughput methodology extend into drug development pipelines, where cardiac safety assessment remains a mandatory yet laborious step. hiPSC-CMs serve as patient-derived models that can recapitulate human cardiac physiology and disease phenotypes in vitro. However, previous bottlenecks in rapid and reproducible electrophysiological characterization curtailed their wider adoption in pharmaceutical screening. Integrating this robotic planar patch-clamp approach can dramatically expedite ion channel screening assays, thus potentially reducing compound attrition rates and improving patient safety by identifying cardiotoxic liabilities earlier and more efficiently.
The integration of multiple patch-clamp protocols in series without disrupting the whole-cell configuration represents a significant leap in experimental design. Typically, one patch-clamp experiment focuses on a single ion channel type or condition per cell. This modular approach enables a holistic functional characterization of several ion currents within a single cell’s lifespan, providing comprehensive electrophysiological fingerprints that can be correlated with genotypic or pharmacological interventions.
Furthermore, the scalable nature of the robotic system allows for application in large-scale studies, including drug screens and large patient cohorts, advancing the vision of precision medicine in cardiology. Researchers can now envisage leveraging vast hiPSC-CM libraries derived from diverse genetic backgrounds to systematically test therapeutic compounds, uncover novel disease mechanisms, and stratify patient risk based on electrophysiological phenotypes.
Beyond its scientific advantages, this protocol reduces time commitments drastically. Experiments that may have previously taken several days or weeks per sample can now be condensed into a single day, maximizing lab productivity and opening time for data analysis and hypothesis-driven inquiries. This acceleration profoundly impacts research timelines and resource allocation, fostering faster bench-to-bedside translation.
The robustness of data derived from planar patch-clamp technology combined with automation also sets a new standard in reproducibility and quality control. By minimizing human error and variability in recording conditions, this methodology assures higher consistency, a persistent challenge in patch-clamp electrophysiology that has historically hindered data comparability across laboratories.
While automated patch-clamp systems are not completely new, the tailored application to hiPSC-CMs with modular, sequential channel testing represents a novel and meaningful advancement. The work of Seibertz and colleagues thus establishes a new paradigm for functional cardiac electrophysiology, marrying technological innovation with biological relevance, and ultimately bridging a critical divide in the translational research landscape.
Looking to the future, the implementation of this protocol might usher in an era where functional electrophysiology is an integral, routine component of multi-omics and phenotypic screening platforms. Combining these electrophysiological insights with transcriptomics, proteomics, and advanced imaging could yield unprecedented mechanistic understandings of cardiac diseases and therapeutic responses.
Moreover, as hiPSC-CM models continue to mature and better emulate adult cardiomyocyte physiology, the utility of such high-throughput patch-clamp measurements will only increase. Indeed, the protocol’s versatility and modularity make it adaptable to evolving cell models and novel ion channel targets, ensuring its relevance for years to come.
In sum, this pioneering effort to automate and enhance the throughput of ion channel current measurements in hiPSC-CMs confronts critical limitations that have long constrained cardiac electrophysiological research. By providing a robust, high-throughput, and accessible solution, this protocol is poised to accelerate cardiac disease modeling, drug safety assessment, and ultimately, the development of targeted cardiac therapeutics, marking a new milestone in cardiovascular science.
—
Subject of Research: Electrophysiological characterization of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) using high-throughput automated planar patch-clamp technology.
Article Title: A modular method for high-throughput measurement of ion channel currents in cardiac myocytes.
Article References:
Seibertz, F., Sobitov, I., Gerloff, M.L. et al. A modular method for high-throughput measurement of ion channel currents in cardiac myocytes. Nat Protoc (2026). https://doi.org/10.1038/s41596-026-01351-z
Image Credits: AI Generated
